Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Contact: Study coordinator (Kathy Schultz, RN) · kschult3@jhmi.edu · 410-614-9482
Contact: Principal Investigator (Laura Sena, MD,PhD)

Study leads

Laura Sena, MD, PhD
Principal Investigator
Johns Hopkins University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Metastatic Castration Resistant Prostate Cancer (mCRPC) · Small Cell Lung Cancer (SCLC) · Follicular Lymphoma (FL)

Abroad (travel likely)RecruitingPHASE1

Tucson, United States · Tucson, United States

ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

Metastatic Castration-resistant Prostate Cancer (mCRPC) · Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Abroad (travel likely)RecruitingPHASE3

Aalst, Belgium · Antwerp, Belgium

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Metastatic Castration-Resistant Prostate Cancer (mCRPC) · Clear Cell Renal Cell Carcinoma (ccRCC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gilbert, United States · Phoenix, United States

Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA

Prostate Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hershey, United States